Interaction between genes and environment in neurodegenerative diseases

被引:56
作者
Elbaz, Alexis [1 ]
Dufouil, Carole [1 ]
Alperovitch, Annick [1 ]
机构
[1] Univ Paris 06, Grp Hosp Pitie Salpetriere, F-75651 Paris 13, France
关键词
Alzheimer disease; parkinson disease; epidemiology; gene; environment;
D O I
10.1016/j.crvi.2007.02.018
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alzheimer's disease (AD) and Parkinson's disease (PD) are highly prevalent disorders that account for a large part of the global burden of neurodegenerative diseases. Most AD and PD cases occur sporadically and it is generally agreed that they could arise through interactions among genetic and environmental factors. Candidate genes involved in the metabolism of xenobiotics, neurodegeneration and functioning of dopaminergic neurons were found to be associated with PD. Some of these genes interact with environmental factors that could modify PD risk. Thus, we found that the inverse association between smoking and the risk of PD depended on a polymorphism of the iNOS (inducible NO synthase) gene. We also found that the cytochrome P450 2D6 gene could have a modifying effect on the risk of PD among persons exposed to pesticides. Both interactions have biological plausibility supported by laboratory studies and could contribute to better understand the aetiology of PD. A single susceptibility gene has been identified in sporadic AD. The epsilon 4 allele of epsilon polymorphism of the apolipoprotein E gene (APOE) is strongly associated with AD, the risk of AD being multiplied by 5 in persons carrying two epsilon 4 alleles. The mechanism of the association between APOE and AD is poorly understood. A few interactions between the epsilon polymorphism and possible risk factors for AD have been described. However, these interactions had no biological plausibility and were likely due to chance.
引用
收藏
页码:318 / 328
页数:11
相关论文
共 78 条
[31]   Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons [J].
Hantraye, P ;
Brouillet, E ;
Ferrante, R ;
Palfi, S ;
Dolan, R ;
Matthews, RT ;
Beal, MF .
NATURE MEDICINE, 1996, 2 (09) :1017-1021
[32]   A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease [J].
Hernán, MA ;
Takkouche, B ;
Caamaño-Isorna, F ;
Gestal-Otero, JJ .
ANNALS OF NEUROLOGY, 2002, 52 (03) :276-284
[33]   Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].
Hofman, A ;
Ott, A ;
Breteler, MMB ;
Bots, ML ;
Slooter, AJC ;
vanHarskamp, F ;
vanDuijn, CN ;
Van Broeckhoven, C ;
Grobbee, DE .
LANCET, 1997, 349 (9046) :151-154
[34]   Nitric oxide synthase and neuronal vulnerability in Parkinson's disease [J].
Hunot, S ;
Boissiere, F ;
Faucheux, B ;
Brugg, B ;
MouattPrigent, A ;
Agid, Y ;
Hirsch, EC .
NEUROSCIENCE, 1996, 72 (02) :355-363
[35]   Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases [J].
Ioannidis, John P. A. ;
Trikalinos, Thomas A. ;
Khoury, Muin J. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (07) :609-614
[36]   What is the evidence for a premorbid parkinsonian personality: A systematic review [J].
Ishihara, Lianna ;
Brayne, Carol .
MOVEMENT DISORDERS, 2006, 21 (08) :1066-1072
[37]   INTERACTIONS OF APOLIPOPROTEIN-E GENOTYPE, TOTAL CHOLESTEROL LEVEL, AGE, AND SEX IN PREDICTION OF ALZHEIMERS-DISEASE - A CASE-CONTROL STUDY [J].
JARVIK, GP ;
WIJSMAN, EM ;
KUKULL, WA ;
SCHELLENBERG, GD ;
YU, C ;
LARSON, EB .
NEUROLOGY, 1995, 45 (06) :1092-1096
[38]   5′ and 3′ region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk:: a hypothesis-generating study [J].
Kelada, Samir N. P. ;
Checkoway, Harvey ;
Kardia, Sharon L. R. ;
Carlson, Christopher S. ;
Costa-Mallen, Paola ;
Eaton, David L. ;
Firestone, Jordan ;
Powers, Karen M. ;
Swanson, Phillip D. ;
Franklin, Gary M. ;
Longstreth, W. T., Jr. ;
Weller, Terri-Smith ;
Afsharinejad, Zahra ;
Costa, Lucio G. .
HUMAN MOLECULAR GENETICS, 2006, 15 (20) :3055-3062
[39]   Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease [J].
Kivipelto, M ;
Helkala, EL ;
Laakso, MP ;
Hänninen, T ;
Hallikainen, M ;
Alhainen, K ;
Iivonen, S ;
Mannermaa, A ;
Tuomilehto, J ;
Nissinen, A ;
Soininen, H .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (03) :149-155
[40]   Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo [J].
Kortekaas, R ;
Leenders, KL ;
van Oostrom, JCH ;
Vaalburg, W ;
Bart, J ;
Willemsen, ATM ;
Hendrikse, NH .
ANNALS OF NEUROLOGY, 2005, 57 (02) :176-179